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 A b s t r a c t: Objective: The aim of the study was to investigate the association 
between foetal growth and different maternal metabolic characteristics in women with 
gestational diabetes mellitus (GDM).  
 Methods: The study group included 200 consecutive pregnant women who 
attended the Endocrinology, Diabetes and Metabolic Disorders Outpatient Department 
in the period from 02.2006 to 02.2009 with singleton pregnancy and GDM diagnosed 
following ADA criteria. The following parameters were studied: pre-pregnancy mater-
nal body mass index (BMI), 3-hours 100g oral glucose tolerance test (OGTT) results, 
glycosylated haemoglobin (HbA1c), total lipids (TL), total cholesterol (TH), triglyce-
rides (TG), HDL- and LDL-cholesterol levels at admission. Neonatal birth weight and 
the prevalence of being large for gestational age (LGA) was an end-point.  
 Results: We found a significant association between birth weight and pre-preg-
nancy BMI, HDL-C and birth weight of a large child born previously. Birth weight of a 
large child born previously was the strongest independent predictor for LGA. The pre-
valence of LGA (from 27% to 80%) was related to a number of altered maternal 
characteristics.  
 Conclusion: Pre-pregnancy BMI, HDL-C and birth weight of a large child born 
previously are the independent predictors for LGA, but results of glucose levels during 
OGTT are not useful in the prediction of LGA in GDM pregnancies. Probably more 
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factors and other maternal metabolic parameters than glucose levels during OGTT are 
responsible for the risk of LGA. 
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Introduction 
 
 Foetal growth is affected by genetic, demographic and metabolic factors 
of the mother [1]. In particular, disturbances of maternal glucose metabolism 
are known to favour foetal overgrowth and macrosomia, a major complication 
of GDM [2, 3].  
 GDM is defined as a carbohydrate intolerance that begins or is first 
diagnosed during pregnancy [4]. GDM, also known as glucose intolerance of 
pregnancy, affects about 100,000 women every year. Pregnancies complicated 
with GDM are at increased risk of neonatal mortality and morbidity, mainly as a 
result of foetal macrosomia as well as operative and instrumental deliveries, 
birth trauma and metabolic abnormalities in the newborn [5, 6].  
 The major reason for poor perinatal outcome is foetal macrosomia (de-
fined as large for gestational age, with a birth weight above the 90th percentile; 
LGA). Foetal overgrowth induced by foetal hyperinsulinaemia can develop as a 
response to increased placental glucose transfer to the foetus which is secondary 
to maternal hyperglycaemia [7]. Therefore, normalization of foetal growth is a 
principle in the management of pregnancies with diabetes.  
 In recent decades, significant improvements in perinatal care, diagnosis 
and treatment of GDM complicated pregnancies have been made. Despite this, 
macrosomia still remains a serious problem, which may complicate up to 30% of 
diabetic pregnancies [1, 8]. Interestingly, a certain percentage of newborns with 
macrosomia remains high even in women with proper carbohydrate controls, 
measured using commonly available parameters (fasting and 2-hrs postprandial 
glycemia, HbA1c concentration) [9]. Therefore, further studies are necessary to 
investigate other factors contributing to foetal overgrowth in diabetic pregnancy [7]. 
 There is no doubt from the literature that maternal glycaemia in women 
with GDM is involved in determining birth weight, but whether there is any in-
fluence of maternal glycaemia during OGTT on foetal macrosomia is unknown 
[10]. In recent studies foetal growth and development is considered a complex 
process where maternal characteristics, foetal potential and the intrauterine en-
vironment play an important role [9]. The list of factors influencing foetal 
growth both in normal and in diabetic pregnancy is expanding and is still far 
from being complete. Results of different studies are often conflicting and new 
areas for research are emerging [11]. Recently, a great deal of data has accu-
mulated on lipid metabolism in normal and diabetic pregnancies, maternal 
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obesity and gestational insulin resistance; however, data concerning their impact on 
foetal growth are limited [12–15]. Pregnancy is commonly described as a condi-
tion characterized by a rapid increase in all lipids; however, evidence concer-
ning the relationship between lipid metabolism and hormonal changes during 
foetal gestation is conflicting [16].  
 In our study we aim to investigate different maternal metabolic chara-
cteristics and their compounding influence on foetal growth and the incidence 
of LGA in pregnant women with GDM. 
 
 
Material and methods 
 
 The study was conducted from 02.2006 to 02.2009, at the Endocrino-
logy, Diabetes and Metabolic Disorders Outpatient Department in Skopje, R. 
Macedonia. Two hundred consecutive pregnant women in whom gestational 
diabetes was diagnosed were included in this study. According to the guidelines 
of the ADA [17] we used the 2 steps system. A glucose challenge test (GCT) 
was performed between the 24th and 28th weeks of gestation in high and 
middle risk groups of pregnant patients. In GCT, the pregnant women under-
went a standard 50-g glucose load and a 1-h plasma glucose concentration was 
measured. A plasma glucose ≥ 7.8 mmol/l was considered positive according to 
these recommendations. All women with positive GCT performed a diagnostic 
3-h 100-g oral glucose tolerance test (OGTT). After an overnight fast and at 
least 3 days of unrestricted diet (≥ 150 g carbohydrate per day) and unlimited 
physical activity, blood was taken to determinate plasma glucose levels. Accor-
ding to Carpenter and Coustan’s criteria [18] the cut-off values were the follo-
wing: fasting glycaemia: 5.3 mmol/l, 1 h: 10.0 mmol/l, 2 h: 8.6 mmol/ l, 3 h: 7.8 
mmol/l. Two or more of the cut-off values must be met or exceeded for a dia-
gnosis of GDM. Capillary blood glucose levels were measured by glucose oxi-
dase (Glucose Analyzer; Beckman, Brea, CA). 
 Further inclusion criteria were: singleton pregnancy, live birth and no 
foetal malformation suspected during gestation or detected postpartum. All pa-
tients gave informed consent to participate in the study.  
 In our research, we investigated the following parameters: the patient’s 
age, pre-pregnancy body mass index (BMI), gestational age when GDM was 
diagnosed, glycaemia levels of 100g OGTT (fasting, 2-h and 3-h post-load gly-
caemia), TL, TH, HDL-C, LDL-C, TG, HbA1c concentration and arterial blood 
pressure at booking. We also recorded the birth weight of the largest child born 
in a previous pregnancy (if applicable). Birth weight and the proportion of LGA 
(defined as a birth weight of > 90th percentile for local population after adjust-
ting for gestational age and sex) were studied at the end-point. 
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Blood samples for HbA1c and lipid assessment were taken after over-
night fasting. The blood samples for lipoproteins were analyzed using Cobas 
Integra 700, according to standard methods. TH and triglycerides were determi-
ned by full enzymatic methods (TH-CHOD-POD-PAP and triglycerides-GPO; 
Cobas Integra 700, Hoffmann-La Roche, Basel, Switzerland). HDL-C was mea-
sured by the polyanion precipitation method, while LDL-C was calculated using 
the Friedewald formula. LDL-C were fractioned using ultracentrifugation in 
cases of triglycerides exceeding 4mmol/l. HbA1c was measured by an ion-
exchange HPLC instrument (DS5; Drew, USA) with a reference range of 4.2–
6%. Blood pressure was measured twice in a supine position. In a case of hyper-
tension (> 145/90 mmHg) the measurement was repeated after five minutes. 
The patients were weighed wearing clothes without shoes in the morning of the 
first visit with an electronic scale. Height was measured to the nearest 1 cm with 
a stadiometer. 
For the purposes of this study, we initially investigated bivariate corre-
lations between the maternal parameters and birth weight, while features that 
correlated significantly with a birth weight were chosen for further calculations. 
We analysed the distribution of the following covariates: fasting, 2-h and 3-h 
post-load glycaemia in 100g OGTT, HbA1c level, pre-pregnancy BMI, TL, TH, 
LDL-C, HDL-C, TG concentration and birth weight of the largest child born in 
a previous pregnancy. Then, we defined values above the 75th percentile as 
altered, except for HDL, which was described as altered if below the 25th per-
centile. As a next step, we retrospectively divided the study group into three 
subgroups according to the number of altered parameters found in each partici-
pant: from 0 if all of the following: BMI, HDL-C concentration and birth weight of 
the largest child born in a previous pregnancy were within interquartile range 
(i.e. between 25th and 75th percentile) to 3 if all of them were altered. Then the 
birth weight and prevalence of LGA were studied across the subgroups. 
 
 
Statistical analysis 
 
Statistical analysis was performed using the Statistics for Windows 
programme, version 5, 0. Associations between birth weight and maternal meta-
bolic parameters were analysed using Spearman rank correlation coefficients. 
Linear regression analysis was performed to find independent predictors for 
birth weight in the study group. The significance of the differences between 
study groups was tested using the Kruskall-Wallis test. Differences in cate-
gorical variables were tested using a chi-square statistic. P < 0.05 was consi-
dered statistically significant. 
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Results  
 
 Basic characteristics of the patients enrolled in the study are given in 
Table1. Hypertension was diagnosed in 7% of individuals. 
 
Table 1 – Табела 1 
 
Characteristics of study group 
Каракtерисtики на исpиtуванаtа gруpа 
Number of patients studied N = 200 
Age (years) 31 (18–47) 
Proportion of individuals > 30 years 55% 
Pre-pregnancy BMI (kg/m2) 26.64 (17–46) 
Gestational age at diagnosis  
(week of gestation) 28 (6–40) 
Fasting glycaemia in 100g OGTT 
(mmol/l) 5.8 (4.2–11.7) 
2h post-load glycaemia in 100g OGTT 
(mmol/l) 9.4 (4.3–17.6) 
3h post-load glycaemia in 100g OGTT 
(mmol/l) 6.7 (3–13.5) 
HbA1c at booking (%) 5.7 (3.8–11) 
Proportion of patients with Hb1c at 
booking 6.0% 36.17 
Gestational age at delivery  
(week of gestation) 39 (30–42) 
Birth weight (g) 3500 (1450–5410) 
Proportion of LGA (%) 31.5 
insulin/ diet treated GDM 51/200 
Hypertensive/ normotensive individuals 14/200 
Data given as median (minimum-maximum value) 
Податоците се прикажани како медијана (минимална-максимална вредност) 
  
 We found a positive significant correlation between birth weight and 
pre-pregnancy BMI (r = 0.18, p = 0.01), birth weight of the largest child born 
before (r = 0.32, p = 0.02) and HDL-C (r = -0.22, p = 0.001) at booking. No 
correlation was found for maternal age, gestational age when GDM was diagno-
sed, HbA1c, TL, TG, TH, LDL-C, fasting, 2-h or 3h post-load glycaemia in 
100g OGTT. 
 To determine independent predictors of birth weight in our study group, 
we used linear multiple regression analysis with birth weight as a dependent 
variable and maternal characteristics as independent variables. Results of the 
regression analysis are given in Table 2.  
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Table 2 – Табела 2 
 
Independent predictors of birth weight in study group 
Независни pредикtори на родилнаtа tежина во исpиtуванаtа gруpа 
Covariates R2 p 
Pre-pregnancy BMI 0.062 < 0.001 
Birth weight-largest child born before 0.081 < 0.01 
HDL-C 0.06 < 0.05 
  
 Univariate analysis demonstrated that birth weight of the largest child 
born before was the strongest independent predictor of a birth weight in our 
study group, accounting for around 8% of the variation. Pre-pregnancy BMI and 
HDL-C alone predicted 6% of the variation in the dependent variable.  
 We also involved investigation of the combined influence of metabolic 
alterations and birth weight of the largest child born before on birth weight and 
the prevalence of macrosomia. Distributions of these parameters are given in 
Table 3. At the end we analysed birth weight and the proportion of LGA new-
borns in the subgroup of individuals with different numbers of altered parame-
ters. We used values for particular characteristics given in Table 3 above the 
75th percentile and below the 25th percentile for HDL-C. Results are given in 
Table 4 and Fig.1.  
 
Table 3 – Табела 3 
 
Distribution of metabolic characteristics and birth weight 
of largest child born previously 
Дисtрибуција на меtаболниtе каракtерисtики и родилнаtа tежина 
на најgолемоtо деtе родено pреtходно 
Variables 25th percentile 75th percentile 
Pre-pregnancy BMI (kg/m2) 23 30 
Birth weight-largest child 
born before (g) 3200 4000 
HDL-C (mmol/l) 1.3 1.8 
  
 We found a significant difference in birth weight and the prevalence of 
LGA when comparing pregnant women with the different numbers of altered 
characteristics (values within the highest or the lowest quartile). the proportion 
of macrosomic newborns varied from 27% in individuals with no abnormalities 
to 80% in patients with 3 characteristics changed.  
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Table 4 – Табела 4  
 
Birth weight and % of LGA newborns in relation to altered characteristics 
Родилна tежина и % од ГГВ новородени во релација со pроменеtиtе 
каракtерисtики 
Number of altered 
characteristics N Birth weight (g) % of LGA 
0 43 3529 ± 489 27.9% 
1 34 3579 ± 941 41.2% 
2 14 3809 ± 960 64.3% 
3 5 4640 ± 250 80% 
p  < 0.01* < 0.001** 
* Kruskal-Wallis test ** Chi2 test 
Maternal metabolic characteristics defined as altered: pre-pregnancy BMI above 75th percentile, 
birth weight of largest child born previously above 75th percentile, HDL-C concentration below 
25th percentile. 
Променетите метаболни карактеристики на мајката се дефинирани како: БМИ пред бреме-
ност над 75-от перцентил, родилна тежина на најголемо дете родено претходно над 75-от 
перцентил, концентрации на ХДЛ холестерол под 25-от перцентил. 
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Figure 1 – Birth weight in relation to altered maternal characteristics (p < 0.01) 
Слика 1 – Родилна tежина во релација со pроменеtиtе каракtерисtики 
кај мајкаtа (p < 0.01) 
 
 
Discussion 
 
 In our study we found a significant association between birth weight 
and the following variables: pre-pregnancy BMI, HDL-C and birth weight of a 
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large child born previously. Kitijama et al. [19] analysed the maternal hypertri-
gliceridaemia, maternal fasting plasma glucose, pre-pregnancy BMI and gesta-
tional change in maternal body weight, but only hypertrigliceridaemia was a 
significant risk factor for LGA. The same methodology concerning TG concen-
trations was also applied by Di Cianni et al. [20] who reported a significant 
association between elevated maternal TG levels, pre-pregnancy BMI, weight 
gain during pregnancy and 2-hours OGTT glycaemia. Similar, Lin et al. [21] 
found that fasting glucose on the 100-g OGTT correlates closely with birth 
weight and is an independent risk factor for macrosomia. The latter findings are 
not supported by our results, we did not find that glycaemia values during 100-g 
OGTT or TG are associated or predict neonatal birth weight. Some differences 
in results may be attributed to different ethnic background (Kitijama et al. in-
vestigated Japanese gravitas). We must note that we analysed only glycaemic 
values during 100-g OGTT, not fasting or postprandial glycaemic values during 
pregnancy. Clausen et al. [22] did not find that TG levels before 20 weeks of 
gestation are associated with birth weigh. But later in pregnancy TG levels were 
independent predictors for birth weight. Thus, maternal TG levels may be a 
significant determinant of foetal overgrowth in our study, too, but in late and 
not in early pregnancy when we measured TG. We found that low serum HDL-
C was associated with an increased risk of LGA, independent of BMI as in the 
Clausen et al. results. 
 Recent studies have consistently shown that maternal BMI is a strong 
independent predictor of the birth weight in GDM pregnancies [19, 22, 23]. In 
their study, Charlotte et al. [24] concluded that maternal obesity is a major risk 
factor for LGA in pregnancies complicated by gestational diabetes. According 
to them, the incidence of LGA infants was significantly higher in obese women 
than in those with lower BMI, which is comparable with our findings. Because 
our results show that maternal obesity is a predictor for LGA in GDM, an active 
approach should be taken to obesity among women of childbearing age.  
 The percentage of LGA newborns in our study group was 31.5%, which 
is higher in comparison with findings in past studies [19]. Also, in our study we 
report a significant increase (almost eight-fold) in the prevalence of LGA fol-
lowing the presence of altered maternal characteristics. Upon closer analysis, 
we observed that all the patients with 2 altered characteristics had elevated 
BMI, accompanied by a significant increase in birth weight. Our results suggest 
that foetal overgrowth seems to be driven by other factors, possibly a cluster of 
metabolic alterations associated with maternal obesity, as we observed elevated 
maternal BMI in 36.5% of LGA in our study group. These results are almost 
identical with the results of Zawiejska et al. [7]. They also found that the birth 
weight of the largest child born previously was the strongest independent 
predictor of a birth weight, even stronger (19%) than in our study. Skjaren et al. 
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documented that women who have given birth to an LGA infant once before are 
much more likely to do so again [25].  
 Maybe different factors are responsible for foetal overgrowth at dif-
ferent gestational ages. However, a number of maternal characteristics are res-
ponsible for LGA in GDM. Further studies are necessary to confirm our fin-
dings. 
 
 
Conclusion 
 
 Pre-pregnancy BMI, HDL-C (during pregnancy) and birth weight of a 
large child born previously are the independent predictors for LGA, but results 
of glucose levels during OGTT are not useful in the prediction of LGA in GDM 
pregnancies. Probably several factors and other maternal metabolic parameters 
than glucose levels during OGTT are responsible for the risk of LGA.   
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МЕТАБОЛНИ КАРАКТЕРИСТИКИ НА МАЈКИ СО ГЕСТАЦИСКИ 
ДИЈАБЕТЕС 
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 Цел: Да откриеме дали постои асоцијација помеѓу феталниот раст и мета-
болните карактеристики на мајки со гестациски дијабетес (ГДМ). 
 Маtеријали и меtоди: Во студијата беа вклучени 200 последователни 
бремени жени кои се јавија на Клиниката за ендокринологија, дијабетес и мета-
болни нарушувања во Скопје, во периодот од 02.2006 до 02.2009 со единечна бре-
меност и дијагностициран ГДМ според ADA критериуми. На учесниците им беа 
испитувани следните параметри: индекс на телесна маса пред бременост, 100 гр 
орален глукозен толерас тест (ОГТТ), гликолизиран хемоглобин, вкупни липиди, 
вкупен холестерол, триглицериди, HDL-, LDL-холестерол. Родилната телесна 
тежина и преваленцата на голема телесна тежина за гестациската возраст (ГГВ) 
беа крајна цел на испитувањето. 
 Резулtаtи: Постоеше статистички значајна асоцијација помеѓу родил-
ната тежина и индексот на телесна маса пред бременоста на мајката, HDL-C и ро-
дилната тежина на најтешкото дете родено претходно. Родилната тежина на нај-
тешкото дете родено претходно се покажа како најсилен независен фактор за ГГВ. 
Преваленцата на ГГВ се зголемуваше (од 27% до 80%) со зголемување на бројот 
на променетите карактеристики на мајката.  
 Заклучок: За разлика од индексот на телесна маса пред бременоста на 
мајката, HDL-C (за време на бременоста) и родилната тежина на најтешкото дете 
родено претходно, резултатите од ОГТТ не се корисни во предвидувањето на 
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ГГВ. Веројатно повеќе фактори и метаболни параметри на мајката различни од 
нивото на гликоза за време на ОГТТ се одговорни за ГГВ кај оваа група на па-
циентки.  
 
Клучни зборови: гестациски дијабетес, голема телесна тежина за гестациската 
возраст, макросомија, метаболни параметри, ОГТТ. 
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